* Phibro Animal Health Corp PAHC.OQ PAHC.O is expected
to show
a rise in quarterly revenue when it reports results on February
8.
* The Teaneck New Jersey-based company is expected to
report a
3.7% increase in revenue to $241.285 million from $232.7 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Phibro Animal
Health Corp
is for earnings of 30 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Phibro
Animal
Health Corp is $17.5, above its last closing price of $16.26.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.27 0.27 0.21 Missed -20.9
Jun. 30 2022 0.38 0.38 0.26 Missed -32.1
Mar. 31 2022 0.35 0.35 0.33 Missed -6.6
Dec. 31 2021 0.32 0.33 0.37 Beat 13.3
Sep. 0.27 0.29 0.25 Missed -14.8
30 2021
Jun. 30 2021 0.32 0.31 0.32 Beat 2.5
Mar. 31 2021 0.32 0.34 0.34 Met 1.3
Dec. 31 2020 0.27 0.27 0.34 Beat 27.3
This summary was machine generated February 6 at 23:10 GMT. All
figures in US dollars unless otherwise stated